Global Radioisotopes in Medicine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Radioisotopes in Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Radioisotopes in Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Radioisotopes in Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Radioisotopes in Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Radioisotopes in Medicine players cover NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
LPI (LP Information)' newest research report, the “Radioisotopes in Medicine Industry Forecast” looks at past sales and reviews total world Radioisotopes in Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Radioisotopes in Medicine sales for 2023 through 2029. With Radioisotopes in Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioisotopes in Medicine industry.
This Insight Report provides a comprehensive analysis of the global Radioisotopes in Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radioisotopes in Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Radioisotopes in Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioisotopes in Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioisotopes in Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Radioisotopes in Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Radioisotopes in Medicine market?
What factors are driving Radioisotopes in Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radioisotopes in Medicine market opportunities vary by end market size?
How does Radioisotopes in Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Radioisotopes in Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Radioisotopes in Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Radioisotopes in Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Radioisotopes in Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Radioisotopes in Medicine players cover NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
LPI (LP Information)' newest research report, the “Radioisotopes in Medicine Industry Forecast” looks at past sales and reviews total world Radioisotopes in Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Radioisotopes in Medicine sales for 2023 through 2029. With Radioisotopes in Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioisotopes in Medicine industry.
This Insight Report provides a comprehensive analysis of the global Radioisotopes in Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radioisotopes in Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Radioisotopes in Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioisotopes in Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioisotopes in Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Radioisotopes in Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Tc-99m
- Cobalt-60
- Iodine Radioisotopes
- Others
- Nuclear Therapy
- Equipment Radioactive Source
- Diagnosis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NRG
- IRE
- ANSTO
- NTP Radioisotopes
- China National Nuclear Corporation
- Rosatom
- Nordion
- Eckert & Ziegler Strahlen
- Polatom
- SHINE Technologies
- NorthStar Medical Radioisotopes
What is the 10-year outlook for the global Radioisotopes in Medicine market?
What factors are driving Radioisotopes in Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radioisotopes in Medicine market opportunities vary by end market size?
How does Radioisotopes in Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radioisotopes in Medicine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Radioisotopes in Medicine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Radioisotopes in Medicine by Country/Region, 2018, 2022 & 2029
2.2 Radioisotopes in Medicine Segment by Type
2.2.1 Tc-99m
2.2.2 Cobalt-60
2.2.3 Iodine Radioisotopes
2.2.4 Others
2.3 Radioisotopes in Medicine Sales by Type
2.3.1 Global Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
2.3.2 Global Radioisotopes in Medicine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Radioisotopes in Medicine Sale Price by Type (2018-2023)
2.4 Radioisotopes in Medicine Segment by Application
2.4.1 Nuclear Therapy
2.4.2 Equipment Radioactive Source
2.4.3 Diagnosis
2.5 Radioisotopes in Medicine Sales by Application
2.5.1 Global Radioisotopes in Medicine Sale Market Share by Application (2018-2023)
2.5.2 Global Radioisotopes in Medicine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Radioisotopes in Medicine Sale Price by Application (2018-2023)
3 GLOBAL RADIOISOTOPES IN MEDICINE BY COMPANY
3.1 Global Radioisotopes in Medicine Breakdown Data by Company
3.1.1 Global Radioisotopes in Medicine Annual Sales by Company (2018-2023)
3.1.2 Global Radioisotopes in Medicine Sales Market Share by Company (2018-2023)
3.2 Global Radioisotopes in Medicine Annual Revenue by Company (2018-2023)
3.2.1 Global Radioisotopes in Medicine Revenue by Company (2018-2023)
3.2.2 Global Radioisotopes in Medicine Revenue Market Share by Company (2018-2023)
3.3 Global Radioisotopes in Medicine Sale Price by Company
3.4 Key Manufacturers Radioisotopes in Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radioisotopes in Medicine Product Location Distribution
3.4.2 Players Radioisotopes in Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RADIOISOTOPES IN MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Radioisotopes in Medicine Market Size by Geographic Region (2018-2023)
4.1.1 Global Radioisotopes in Medicine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Radioisotopes in Medicine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Radioisotopes in Medicine Market Size by Country/Region (2018-2023)
4.2.1 Global Radioisotopes in Medicine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Radioisotopes in Medicine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Radioisotopes in Medicine Sales Growth
4.4 APAC Radioisotopes in Medicine Sales Growth
4.5 Europe Radioisotopes in Medicine Sales Growth
4.6 Middle East & Africa Radioisotopes in Medicine Sales Growth
5 AMERICAS
5.1 Americas Radioisotopes in Medicine Sales by Country
5.1.1 Americas Radioisotopes in Medicine Sales by Country (2018-2023)
5.1.2 Americas Radioisotopes in Medicine Revenue by Country (2018-2023)
5.2 Americas Radioisotopes in Medicine Sales by Type
5.3 Americas Radioisotopes in Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radioisotopes in Medicine Sales by Region
6.1.1 APAC Radioisotopes in Medicine Sales by Region (2018-2023)
6.1.2 APAC Radioisotopes in Medicine Revenue by Region (2018-2023)
6.2 APAC Radioisotopes in Medicine Sales by Type
6.3 APAC Radioisotopes in Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radioisotopes in Medicine by Country
7.1.1 Europe Radioisotopes in Medicine Sales by Country (2018-2023)
7.1.2 Europe Radioisotopes in Medicine Revenue by Country (2018-2023)
7.2 Europe Radioisotopes in Medicine Sales by Type
7.3 Europe Radioisotopes in Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radioisotopes in Medicine by Country
8.1.1 Middle East & Africa Radioisotopes in Medicine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Radioisotopes in Medicine Revenue by Country (2018-2023)
8.2 Middle East & Africa Radioisotopes in Medicine Sales by Type
8.3 Middle East & Africa Radioisotopes in Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radioisotopes in Medicine
10.3 Manufacturing Process Analysis of Radioisotopes in Medicine
10.4 Industry Chain Structure of Radioisotopes in Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radioisotopes in Medicine Distributors
11.3 Radioisotopes in Medicine Customer
12 WORLD FORECAST REVIEW FOR RADIOISOTOPES IN MEDICINE BY GEOGRAPHIC REGION
12.1 Global Radioisotopes in Medicine Market Size Forecast by Region
12.1.1 Global Radioisotopes in Medicine Forecast by Region (2024-2029)
12.1.2 Global Radioisotopes in Medicine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radioisotopes in Medicine Forecast by Type
12.7 Global Radioisotopes in Medicine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 NRG
13.1.1 NRG Company Information
13.1.2 NRG Radioisotopes in Medicine Product Portfolios and Specifications
13.1.3 NRG Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 NRG Main Business Overview
13.1.5 NRG Latest Developments
13.2 IRE
13.2.1 IRE Company Information
13.2.2 IRE Radioisotopes in Medicine Product Portfolios and Specifications
13.2.3 IRE Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 IRE Main Business Overview
13.2.5 IRE Latest Developments
13.3 ANSTO
13.3.1 ANSTO Company Information
13.3.2 ANSTO Radioisotopes in Medicine Product Portfolios and Specifications
13.3.3 ANSTO Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ANSTO Main Business Overview
13.3.5 ANSTO Latest Developments
13.4 NTP Radioisotopes
13.4.1 NTP Radioisotopes Company Information
13.4.2 NTP Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
13.4.3 NTP Radioisotopes Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 NTP Radioisotopes Main Business Overview
13.4.5 NTP Radioisotopes Latest Developments
13.5 China National Nuclear Corporation
13.5.1 China National Nuclear Corporation Company Information
13.5.2 China National Nuclear Corporation Radioisotopes in Medicine Product Portfolios and Specifications
13.5.3 China National Nuclear Corporation Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 China National Nuclear Corporation Main Business Overview
13.5.5 China National Nuclear Corporation Latest Developments
13.6 Rosatom
13.6.1 Rosatom Company Information
13.6.2 Rosatom Radioisotopes in Medicine Product Portfolios and Specifications
13.6.3 Rosatom Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Rosatom Main Business Overview
13.6.5 Rosatom Latest Developments
13.7 Nordion
13.7.1 Nordion Company Information
13.7.2 Nordion Radioisotopes in Medicine Product Portfolios and Specifications
13.7.3 Nordion Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nordion Main Business Overview
13.7.5 Nordion Latest Developments
13.8 Eckert & Ziegler Strahlen
13.8.1 Eckert & Ziegler Strahlen Company Information
13.8.2 Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolios and Specifications
13.8.3 Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Eckert & Ziegler Strahlen Main Business Overview
13.8.5 Eckert & Ziegler Strahlen Latest Developments
13.9 Polatom
13.9.1 Polatom Company Information
13.9.2 Polatom Radioisotopes in Medicine Product Portfolios and Specifications
13.9.3 Polatom Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Polatom Main Business Overview
13.9.5 Polatom Latest Developments
13.10 SHINE Technologies
13.10.1 SHINE Technologies Company Information
13.10.2 SHINE Technologies Radioisotopes in Medicine Product Portfolios and Specifications
13.10.3 SHINE Technologies Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 SHINE Technologies Main Business Overview
13.10.5 SHINE Technologies Latest Developments
13.11 NorthStar Medical Radioisotopes
13.11.1 NorthStar Medical Radioisotopes Company Information
13.11.2 NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
13.11.3 NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 NorthStar Medical Radioisotopes Main Business Overview
13.11.5 NorthStar Medical Radioisotopes Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radioisotopes in Medicine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Radioisotopes in Medicine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Radioisotopes in Medicine by Country/Region, 2018, 2022 & 2029
2.2 Radioisotopes in Medicine Segment by Type
2.2.1 Tc-99m
2.2.2 Cobalt-60
2.2.3 Iodine Radioisotopes
2.2.4 Others
2.3 Radioisotopes in Medicine Sales by Type
2.3.1 Global Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
2.3.2 Global Radioisotopes in Medicine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Radioisotopes in Medicine Sale Price by Type (2018-2023)
2.4 Radioisotopes in Medicine Segment by Application
2.4.1 Nuclear Therapy
2.4.2 Equipment Radioactive Source
2.4.3 Diagnosis
2.5 Radioisotopes in Medicine Sales by Application
2.5.1 Global Radioisotopes in Medicine Sale Market Share by Application (2018-2023)
2.5.2 Global Radioisotopes in Medicine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Radioisotopes in Medicine Sale Price by Application (2018-2023)
3 GLOBAL RADIOISOTOPES IN MEDICINE BY COMPANY
3.1 Global Radioisotopes in Medicine Breakdown Data by Company
3.1.1 Global Radioisotopes in Medicine Annual Sales by Company (2018-2023)
3.1.2 Global Radioisotopes in Medicine Sales Market Share by Company (2018-2023)
3.2 Global Radioisotopes in Medicine Annual Revenue by Company (2018-2023)
3.2.1 Global Radioisotopes in Medicine Revenue by Company (2018-2023)
3.2.2 Global Radioisotopes in Medicine Revenue Market Share by Company (2018-2023)
3.3 Global Radioisotopes in Medicine Sale Price by Company
3.4 Key Manufacturers Radioisotopes in Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radioisotopes in Medicine Product Location Distribution
3.4.2 Players Radioisotopes in Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RADIOISOTOPES IN MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Radioisotopes in Medicine Market Size by Geographic Region (2018-2023)
4.1.1 Global Radioisotopes in Medicine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Radioisotopes in Medicine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Radioisotopes in Medicine Market Size by Country/Region (2018-2023)
4.2.1 Global Radioisotopes in Medicine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Radioisotopes in Medicine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Radioisotopes in Medicine Sales Growth
4.4 APAC Radioisotopes in Medicine Sales Growth
4.5 Europe Radioisotopes in Medicine Sales Growth
4.6 Middle East & Africa Radioisotopes in Medicine Sales Growth
5 AMERICAS
5.1 Americas Radioisotopes in Medicine Sales by Country
5.1.1 Americas Radioisotopes in Medicine Sales by Country (2018-2023)
5.1.2 Americas Radioisotopes in Medicine Revenue by Country (2018-2023)
5.2 Americas Radioisotopes in Medicine Sales by Type
5.3 Americas Radioisotopes in Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radioisotopes in Medicine Sales by Region
6.1.1 APAC Radioisotopes in Medicine Sales by Region (2018-2023)
6.1.2 APAC Radioisotopes in Medicine Revenue by Region (2018-2023)
6.2 APAC Radioisotopes in Medicine Sales by Type
6.3 APAC Radioisotopes in Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radioisotopes in Medicine by Country
7.1.1 Europe Radioisotopes in Medicine Sales by Country (2018-2023)
7.1.2 Europe Radioisotopes in Medicine Revenue by Country (2018-2023)
7.2 Europe Radioisotopes in Medicine Sales by Type
7.3 Europe Radioisotopes in Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radioisotopes in Medicine by Country
8.1.1 Middle East & Africa Radioisotopes in Medicine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Radioisotopes in Medicine Revenue by Country (2018-2023)
8.2 Middle East & Africa Radioisotopes in Medicine Sales by Type
8.3 Middle East & Africa Radioisotopes in Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radioisotopes in Medicine
10.3 Manufacturing Process Analysis of Radioisotopes in Medicine
10.4 Industry Chain Structure of Radioisotopes in Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radioisotopes in Medicine Distributors
11.3 Radioisotopes in Medicine Customer
12 WORLD FORECAST REVIEW FOR RADIOISOTOPES IN MEDICINE BY GEOGRAPHIC REGION
12.1 Global Radioisotopes in Medicine Market Size Forecast by Region
12.1.1 Global Radioisotopes in Medicine Forecast by Region (2024-2029)
12.1.2 Global Radioisotopes in Medicine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radioisotopes in Medicine Forecast by Type
12.7 Global Radioisotopes in Medicine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 NRG
13.1.1 NRG Company Information
13.1.2 NRG Radioisotopes in Medicine Product Portfolios and Specifications
13.1.3 NRG Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 NRG Main Business Overview
13.1.5 NRG Latest Developments
13.2 IRE
13.2.1 IRE Company Information
13.2.2 IRE Radioisotopes in Medicine Product Portfolios and Specifications
13.2.3 IRE Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 IRE Main Business Overview
13.2.5 IRE Latest Developments
13.3 ANSTO
13.3.1 ANSTO Company Information
13.3.2 ANSTO Radioisotopes in Medicine Product Portfolios and Specifications
13.3.3 ANSTO Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ANSTO Main Business Overview
13.3.5 ANSTO Latest Developments
13.4 NTP Radioisotopes
13.4.1 NTP Radioisotopes Company Information
13.4.2 NTP Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
13.4.3 NTP Radioisotopes Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 NTP Radioisotopes Main Business Overview
13.4.5 NTP Radioisotopes Latest Developments
13.5 China National Nuclear Corporation
13.5.1 China National Nuclear Corporation Company Information
13.5.2 China National Nuclear Corporation Radioisotopes in Medicine Product Portfolios and Specifications
13.5.3 China National Nuclear Corporation Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 China National Nuclear Corporation Main Business Overview
13.5.5 China National Nuclear Corporation Latest Developments
13.6 Rosatom
13.6.1 Rosatom Company Information
13.6.2 Rosatom Radioisotopes in Medicine Product Portfolios and Specifications
13.6.3 Rosatom Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Rosatom Main Business Overview
13.6.5 Rosatom Latest Developments
13.7 Nordion
13.7.1 Nordion Company Information
13.7.2 Nordion Radioisotopes in Medicine Product Portfolios and Specifications
13.7.3 Nordion Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nordion Main Business Overview
13.7.5 Nordion Latest Developments
13.8 Eckert & Ziegler Strahlen
13.8.1 Eckert & Ziegler Strahlen Company Information
13.8.2 Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolios and Specifications
13.8.3 Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Eckert & Ziegler Strahlen Main Business Overview
13.8.5 Eckert & Ziegler Strahlen Latest Developments
13.9 Polatom
13.9.1 Polatom Company Information
13.9.2 Polatom Radioisotopes in Medicine Product Portfolios and Specifications
13.9.3 Polatom Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Polatom Main Business Overview
13.9.5 Polatom Latest Developments
13.10 SHINE Technologies
13.10.1 SHINE Technologies Company Information
13.10.2 SHINE Technologies Radioisotopes in Medicine Product Portfolios and Specifications
13.10.3 SHINE Technologies Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 SHINE Technologies Main Business Overview
13.10.5 SHINE Technologies Latest Developments
13.11 NorthStar Medical Radioisotopes
13.11.1 NorthStar Medical Radioisotopes Company Information
13.11.2 NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
13.11.3 NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 NorthStar Medical Radioisotopes Main Business Overview
13.11.5 NorthStar Medical Radioisotopes Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radioisotopes in Medicine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Radioisotopes in Medicine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tc-99m
Table 4. Major Players of Cobalt-60
Table 5. Major Players of Iodine Radioisotopes
Table 6. Major Players of Others
Table 7. Global Radioisotopes in Medicine Sales by Type (2018-2023) & (K Curie)
Table 8. Global Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
Table 9. Global Radioisotopes in Medicine Revenue by Type (2018-2023) & ($ million)
Table 10. Global Radioisotopes in Medicine Revenue Market Share by Type (2018-2023)
Table 11. Global Radioisotopes in Medicine Sale Price by Type (2018-2023) & (US$/Curie)
Table 12. Global Radioisotopes in Medicine Sales by Application (2018-2023) & (K Curie)
Table 13. Global Radioisotopes in Medicine Sales Market Share by Application (2018-2023)
Table 14. Global Radioisotopes in Medicine Revenue by Application (2018-2023)
Table 15. Global Radioisotopes in Medicine Revenue Market Share by Application (2018-2023)
Table 16. Global Radioisotopes in Medicine Sale Price by Application (2018-2023) & (US$/Curie)
Table 17. Global Radioisotopes in Medicine Sales by Company (2018-2023) & (K Curie)
Table 18. Global Radioisotopes in Medicine Sales Market Share by Company (2018-2023)
Table 19. Global Radioisotopes in Medicine Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Radioisotopes in Medicine Revenue Market Share by Company (2018-2023)
Table 21. Global Radioisotopes in Medicine Sale Price by Company (2018-2023) & (US$/Curie)
Table 22. Key Manufacturers Radioisotopes in Medicine Producing Area Distribution and Sales Area
Table 23. Players Radioisotopes in Medicine Products Offered
Table 24. Radioisotopes in Medicine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Radioisotopes in Medicine Sales by Geographic Region (2018-2023) & (K Curie)
Table 28. Global Radioisotopes in Medicine Sales Market Share Geographic Region (2018-2023)
Table 29. Global Radioisotopes in Medicine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Radioisotopes in Medicine Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Radioisotopes in Medicine Sales by Country/Region (2018-2023) & (K Curie)
Table 32. Global Radioisotopes in Medicine Sales Market Share by Country/Region (2018-2023)
Table 33. Global Radioisotopes in Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Radioisotopes in Medicine Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Radioisotopes in Medicine Sales by Country (2018-2023) & (K Curie)
Table 36. Americas Radioisotopes in Medicine Sales Market Share by Country (2018-2023)
Table 37. Americas Radioisotopes in Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Radioisotopes in Medicine Revenue Market Share by Country (2018-2023)
Table 39. Americas Radioisotopes in Medicine Sales by Type (2018-2023) & (K Curie)
Table 40. Americas Radioisotopes in Medicine Sales by Application (2018-2023) & (K Curie)
Table 41. APAC Radioisotopes in Medicine Sales by Region (2018-2023) & (K Curie)
Table 42. APAC Radioisotopes in Medicine Sales Market Share by Region (2018-2023)
Table 43. APAC Radioisotopes in Medicine Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Radioisotopes in Medicine Revenue Market Share by Region (2018-2023)
Table 45. APAC Radioisotopes in Medicine Sales by Type (2018-2023) & (K Curie)
Table 46. APAC Radioisotopes in Medicine Sales by Application (2018-2023) & (K Curie)
Table 47. Europe Radioisotopes in Medicine Sales by Country (2018-2023) & (K Curie)
Table 48. Europe Radioisotopes in Medicine Sales Market Share by Country (2018-2023)
Table 49. Europe Radioisotopes in Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Radioisotopes in Medicine Revenue Market Share by Country (2018-2023)
Table 51. Europe Radioisotopes in Medicine Sales by Type (2018-2023) & (K Curie)
Table 52. Europe Radioisotopes in Medicine Sales by Application (2018-2023) & (K Curie)
Table 53. Middle East & Africa Radioisotopes in Medicine Sales by Country (2018-2023) & (K Curie)
Table 54. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Radioisotopes in Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Radioisotopes in Medicine Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Radioisotopes in Medicine Sales by Type (2018-2023) & (K Curie)
Table 58. Middle East & Africa Radioisotopes in Medicine Sales by Application (2018-2023) & (K Curie)
Table 59. Key Market Drivers & Growth Opportunities of Radioisotopes in Medicine
Table 60. Key Market Challenges & Risks of Radioisotopes in Medicine
Table 61. Key Industry Trends of Radioisotopes in Medicine
Table 62. Radioisotopes in Medicine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Radioisotopes in Medicine Distributors List
Table 65. Radioisotopes in Medicine Customer List
Table 66. Global Radioisotopes in Medicine Sales Forecast by Region (2024-2029) & (K Curie)
Table 67. Global Radioisotopes in Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Radioisotopes in Medicine Sales Forecast by Country (2024-2029) & (K Curie)
Table 69. Americas Radioisotopes in Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Radioisotopes in Medicine Sales Forecast by Region (2024-2029) & (K Curie)
Table 71. APAC Radioisotopes in Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Radioisotopes in Medicine Sales Forecast by Country (2024-2029) & (K Curie)
Table 73. Europe Radioisotopes in Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Radioisotopes in Medicine Sales Forecast by Country (2024-2029) & (K Curie)
Table 75. Middle East & Africa Radioisotopes in Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Radioisotopes in Medicine Sales Forecast by Type (2024-2029) & (K Curie)
Table 77. Global Radioisotopes in Medicine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Radioisotopes in Medicine Sales Forecast by Application (2024-2029) & (K Curie)
Table 79. Global Radioisotopes in Medicine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. NRG Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 81. NRG Radioisotopes in Medicine Product Portfolios and Specifications
Table 82. NRG Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 83. NRG Main Business
Table 84. NRG Latest Developments
Table 85. IRE Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 86. IRE Radioisotopes in Medicine Product Portfolios and Specifications
Table 87. IRE Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 88. IRE Main Business
Table 89. IRE Latest Developments
Table 90. ANSTO Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 91. ANSTO Radioisotopes in Medicine Product Portfolios and Specifications
Table 92. ANSTO Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 93. ANSTO Main Business
Table 94. ANSTO Latest Developments
Table 95. NTP Radioisotopes Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 96. NTP Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
Table 97. NTP Radioisotopes Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 98. NTP Radioisotopes Main Business
Table 99. NTP Radioisotopes Latest Developments
Table 100. China National Nuclear Corporation Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 101. China National Nuclear Corporation Radioisotopes in Medicine Product Portfolios and Specifications
Table 102. China National Nuclear Corporation Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 103. China National Nuclear Corporation Main Business
Table 104. China National Nuclear Corporation Latest Developments
Table 105. Rosatom Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 106. Rosatom Radioisotopes in Medicine Product Portfolios and Specifications
Table 107. Rosatom Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 108. Rosatom Main Business
Table 109. Rosatom Latest Developments
Table 110. Nordion Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 111. Nordion Radioisotopes in Medicine Product Portfolios and Specifications
Table 112. Nordion Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 113. Nordion Main Business
Table 114. Nordion Latest Developments
Table 115. Eckert & Ziegler Strahlen Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 116. Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolios and Specifications
Table 117. Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 118. Eckert & Ziegler Strahlen Main Business
Table 119. Eckert & Ziegler Strahlen Latest Developments
Table 120. Polatom Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 121. Polatom Radioisotopes in Medicine Product Portfolios and Specifications
Table 122. Polatom Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 123. Polatom Main Business
Table 124. Polatom Latest Developments
Table 125. SHINE Technologies Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 126. SHINE Technologies Radioisotopes in Medicine Product Portfolios and Specifications
Table 127. SHINE Technologies Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 128. SHINE Technologies Main Business
Table 129. SHINE Technologies Latest Developments
Table 130. NorthStar Medical Radioisotopes Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 131. NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
Table 132. NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 133. NorthStar Medical Radioisotopes Main Business
Table 134. NorthStar Medical Radioisotopes Latest Developments
Table 1. Radioisotopes in Medicine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Radioisotopes in Medicine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tc-99m
Table 4. Major Players of Cobalt-60
Table 5. Major Players of Iodine Radioisotopes
Table 6. Major Players of Others
Table 7. Global Radioisotopes in Medicine Sales by Type (2018-2023) & (K Curie)
Table 8. Global Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
Table 9. Global Radioisotopes in Medicine Revenue by Type (2018-2023) & ($ million)
Table 10. Global Radioisotopes in Medicine Revenue Market Share by Type (2018-2023)
Table 11. Global Radioisotopes in Medicine Sale Price by Type (2018-2023) & (US$/Curie)
Table 12. Global Radioisotopes in Medicine Sales by Application (2018-2023) & (K Curie)
Table 13. Global Radioisotopes in Medicine Sales Market Share by Application (2018-2023)
Table 14. Global Radioisotopes in Medicine Revenue by Application (2018-2023)
Table 15. Global Radioisotopes in Medicine Revenue Market Share by Application (2018-2023)
Table 16. Global Radioisotopes in Medicine Sale Price by Application (2018-2023) & (US$/Curie)
Table 17. Global Radioisotopes in Medicine Sales by Company (2018-2023) & (K Curie)
Table 18. Global Radioisotopes in Medicine Sales Market Share by Company (2018-2023)
Table 19. Global Radioisotopes in Medicine Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Radioisotopes in Medicine Revenue Market Share by Company (2018-2023)
Table 21. Global Radioisotopes in Medicine Sale Price by Company (2018-2023) & (US$/Curie)
Table 22. Key Manufacturers Radioisotopes in Medicine Producing Area Distribution and Sales Area
Table 23. Players Radioisotopes in Medicine Products Offered
Table 24. Radioisotopes in Medicine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Radioisotopes in Medicine Sales by Geographic Region (2018-2023) & (K Curie)
Table 28. Global Radioisotopes in Medicine Sales Market Share Geographic Region (2018-2023)
Table 29. Global Radioisotopes in Medicine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Radioisotopes in Medicine Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Radioisotopes in Medicine Sales by Country/Region (2018-2023) & (K Curie)
Table 32. Global Radioisotopes in Medicine Sales Market Share by Country/Region (2018-2023)
Table 33. Global Radioisotopes in Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Radioisotopes in Medicine Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Radioisotopes in Medicine Sales by Country (2018-2023) & (K Curie)
Table 36. Americas Radioisotopes in Medicine Sales Market Share by Country (2018-2023)
Table 37. Americas Radioisotopes in Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Radioisotopes in Medicine Revenue Market Share by Country (2018-2023)
Table 39. Americas Radioisotopes in Medicine Sales by Type (2018-2023) & (K Curie)
Table 40. Americas Radioisotopes in Medicine Sales by Application (2018-2023) & (K Curie)
Table 41. APAC Radioisotopes in Medicine Sales by Region (2018-2023) & (K Curie)
Table 42. APAC Radioisotopes in Medicine Sales Market Share by Region (2018-2023)
Table 43. APAC Radioisotopes in Medicine Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Radioisotopes in Medicine Revenue Market Share by Region (2018-2023)
Table 45. APAC Radioisotopes in Medicine Sales by Type (2018-2023) & (K Curie)
Table 46. APAC Radioisotopes in Medicine Sales by Application (2018-2023) & (K Curie)
Table 47. Europe Radioisotopes in Medicine Sales by Country (2018-2023) & (K Curie)
Table 48. Europe Radioisotopes in Medicine Sales Market Share by Country (2018-2023)
Table 49. Europe Radioisotopes in Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Radioisotopes in Medicine Revenue Market Share by Country (2018-2023)
Table 51. Europe Radioisotopes in Medicine Sales by Type (2018-2023) & (K Curie)
Table 52. Europe Radioisotopes in Medicine Sales by Application (2018-2023) & (K Curie)
Table 53. Middle East & Africa Radioisotopes in Medicine Sales by Country (2018-2023) & (K Curie)
Table 54. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Radioisotopes in Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Radioisotopes in Medicine Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Radioisotopes in Medicine Sales by Type (2018-2023) & (K Curie)
Table 58. Middle East & Africa Radioisotopes in Medicine Sales by Application (2018-2023) & (K Curie)
Table 59. Key Market Drivers & Growth Opportunities of Radioisotopes in Medicine
Table 60. Key Market Challenges & Risks of Radioisotopes in Medicine
Table 61. Key Industry Trends of Radioisotopes in Medicine
Table 62. Radioisotopes in Medicine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Radioisotopes in Medicine Distributors List
Table 65. Radioisotopes in Medicine Customer List
Table 66. Global Radioisotopes in Medicine Sales Forecast by Region (2024-2029) & (K Curie)
Table 67. Global Radioisotopes in Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Radioisotopes in Medicine Sales Forecast by Country (2024-2029) & (K Curie)
Table 69. Americas Radioisotopes in Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Radioisotopes in Medicine Sales Forecast by Region (2024-2029) & (K Curie)
Table 71. APAC Radioisotopes in Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Radioisotopes in Medicine Sales Forecast by Country (2024-2029) & (K Curie)
Table 73. Europe Radioisotopes in Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Radioisotopes in Medicine Sales Forecast by Country (2024-2029) & (K Curie)
Table 75. Middle East & Africa Radioisotopes in Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Radioisotopes in Medicine Sales Forecast by Type (2024-2029) & (K Curie)
Table 77. Global Radioisotopes in Medicine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Radioisotopes in Medicine Sales Forecast by Application (2024-2029) & (K Curie)
Table 79. Global Radioisotopes in Medicine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. NRG Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 81. NRG Radioisotopes in Medicine Product Portfolios and Specifications
Table 82. NRG Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 83. NRG Main Business
Table 84. NRG Latest Developments
Table 85. IRE Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 86. IRE Radioisotopes in Medicine Product Portfolios and Specifications
Table 87. IRE Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 88. IRE Main Business
Table 89. IRE Latest Developments
Table 90. ANSTO Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 91. ANSTO Radioisotopes in Medicine Product Portfolios and Specifications
Table 92. ANSTO Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 93. ANSTO Main Business
Table 94. ANSTO Latest Developments
Table 95. NTP Radioisotopes Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 96. NTP Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
Table 97. NTP Radioisotopes Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 98. NTP Radioisotopes Main Business
Table 99. NTP Radioisotopes Latest Developments
Table 100. China National Nuclear Corporation Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 101. China National Nuclear Corporation Radioisotopes in Medicine Product Portfolios and Specifications
Table 102. China National Nuclear Corporation Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 103. China National Nuclear Corporation Main Business
Table 104. China National Nuclear Corporation Latest Developments
Table 105. Rosatom Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 106. Rosatom Radioisotopes in Medicine Product Portfolios and Specifications
Table 107. Rosatom Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 108. Rosatom Main Business
Table 109. Rosatom Latest Developments
Table 110. Nordion Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 111. Nordion Radioisotopes in Medicine Product Portfolios and Specifications
Table 112. Nordion Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 113. Nordion Main Business
Table 114. Nordion Latest Developments
Table 115. Eckert & Ziegler Strahlen Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 116. Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolios and Specifications
Table 117. Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 118. Eckert & Ziegler Strahlen Main Business
Table 119. Eckert & Ziegler Strahlen Latest Developments
Table 120. Polatom Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 121. Polatom Radioisotopes in Medicine Product Portfolios and Specifications
Table 122. Polatom Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 123. Polatom Main Business
Table 124. Polatom Latest Developments
Table 125. SHINE Technologies Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 126. SHINE Technologies Radioisotopes in Medicine Product Portfolios and Specifications
Table 127. SHINE Technologies Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 128. SHINE Technologies Main Business
Table 129. SHINE Technologies Latest Developments
Table 130. NorthStar Medical Radioisotopes Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 131. NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
Table 132. NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2018-2023)
Table 133. NorthStar Medical Radioisotopes Main Business
Table 134. NorthStar Medical Radioisotopes Latest Developments
LIST OF FIGURES
Figure 1. Picture of Radioisotopes in Medicine
Figure 2. Radioisotopes in Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radioisotopes in Medicine Sales Growth Rate 2018-2029 (K Curie)
Figure 7. Global Radioisotopes in Medicine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Radioisotopes in Medicine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tc-99m
Figure 10. Product Picture of Cobalt-60
Figure 11. Product Picture of Iodine Radioisotopes
Figure 12. Product Picture of Others
Figure 13. Global Radioisotopes in Medicine Sales Market Share by Type in 2022
Figure 14. Global Radioisotopes in Medicine Revenue Market Share by Type (2018-2023)
Figure 15. Radioisotopes in Medicine Consumed in Nuclear Therapy
Figure 16. Global Radioisotopes in Medicine Market: Nuclear Therapy (2018-2023) & (K Curie)
Figure 17. Radioisotopes in Medicine Consumed in Equipment Radioactive Source
Figure 18. Global Radioisotopes in Medicine Market: Equipment Radioactive Source (2018-2023) & (K Curie)
Figure 19. Radioisotopes in Medicine Consumed in Diagnosis
Figure 20. Global Radioisotopes in Medicine Market: Diagnosis (2018-2023) & (K Curie)
Figure 21. Global Radioisotopes in Medicine Sales Market Share by Application (2022)
Figure 22. Global Radioisotopes in Medicine Revenue Market Share by Application in 2022
Figure 23. Radioisotopes in Medicine Sales Market by Company in 2022 (K Curie)
Figure 24. Global Radioisotopes in Medicine Sales Market Share by Company in 2022
Figure 25. Radioisotopes in Medicine Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Radioisotopes in Medicine Revenue Market Share by Company in 2022
Figure 27. Global Radioisotopes in Medicine Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Radioisotopes in Medicine Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Radioisotopes in Medicine Sales 2018-2023 (K Curie)
Figure 30. Americas Radioisotopes in Medicine Revenue 2018-2023 ($ Millions)
Figure 31. APAC Radioisotopes in Medicine Sales 2018-2023 (K Curie)
Figure 32. APAC Radioisotopes in Medicine Revenue 2018-2023 ($ Millions)
Figure 33. Europe Radioisotopes in Medicine Sales 2018-2023 (K Curie)
Figure 34. Europe Radioisotopes in Medicine Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Radioisotopes in Medicine Sales 2018-2023 (K Curie)
Figure 36. Middle East & Africa Radioisotopes in Medicine Revenue 2018-2023 ($ Millions)
Figure 37. Americas Radioisotopes in Medicine Sales Market Share by Country in 2022
Figure 38. Americas Radioisotopes in Medicine Revenue Market Share by Country in 2022
Figure 39. Americas Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
Figure 40. Americas Radioisotopes in Medicine Sales Market Share by Application (2018-2023)
Figure 41. United States Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Radioisotopes in Medicine Sales Market Share by Region in 2022
Figure 46. APAC Radioisotopes in Medicine Revenue Market Share by Regions in 2022
Figure 47. APAC Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
Figure 48. APAC Radioisotopes in Medicine Sales Market Share by Application (2018-2023)
Figure 49. China Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Radioisotopes in Medicine Sales Market Share by Country in 2022
Figure 57. Europe Radioisotopes in Medicine Revenue Market Share by Country in 2022
Figure 58. Europe Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
Figure 59. Europe Radioisotopes in Medicine Sales Market Share by Application (2018-2023)
Figure 60. Germany Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Radioisotopes in Medicine Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Application (2018-2023)
Figure 69. Egypt Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Radioisotopes in Medicine in 2022
Figure 75. Manufacturing Process Analysis of Radioisotopes in Medicine
Figure 76. Industry Chain Structure of Radioisotopes in Medicine
Figure 77. Channels of Distribution
Figure 78. Global Radioisotopes in Medicine Sales Market Forecast by Region (2024-2029)
Figure 79. Global Radioisotopes in Medicine Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Radioisotopes in Medicine Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Radioisotopes in Medicine Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Radioisotopes in Medicine Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Radioisotopes in Medicine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Radioisotopes in Medicine
Figure 2. Radioisotopes in Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radioisotopes in Medicine Sales Growth Rate 2018-2029 (K Curie)
Figure 7. Global Radioisotopes in Medicine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Radioisotopes in Medicine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tc-99m
Figure 10. Product Picture of Cobalt-60
Figure 11. Product Picture of Iodine Radioisotopes
Figure 12. Product Picture of Others
Figure 13. Global Radioisotopes in Medicine Sales Market Share by Type in 2022
Figure 14. Global Radioisotopes in Medicine Revenue Market Share by Type (2018-2023)
Figure 15. Radioisotopes in Medicine Consumed in Nuclear Therapy
Figure 16. Global Radioisotopes in Medicine Market: Nuclear Therapy (2018-2023) & (K Curie)
Figure 17. Radioisotopes in Medicine Consumed in Equipment Radioactive Source
Figure 18. Global Radioisotopes in Medicine Market: Equipment Radioactive Source (2018-2023) & (K Curie)
Figure 19. Radioisotopes in Medicine Consumed in Diagnosis
Figure 20. Global Radioisotopes in Medicine Market: Diagnosis (2018-2023) & (K Curie)
Figure 21. Global Radioisotopes in Medicine Sales Market Share by Application (2022)
Figure 22. Global Radioisotopes in Medicine Revenue Market Share by Application in 2022
Figure 23. Radioisotopes in Medicine Sales Market by Company in 2022 (K Curie)
Figure 24. Global Radioisotopes in Medicine Sales Market Share by Company in 2022
Figure 25. Radioisotopes in Medicine Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Radioisotopes in Medicine Revenue Market Share by Company in 2022
Figure 27. Global Radioisotopes in Medicine Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Radioisotopes in Medicine Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Radioisotopes in Medicine Sales 2018-2023 (K Curie)
Figure 30. Americas Radioisotopes in Medicine Revenue 2018-2023 ($ Millions)
Figure 31. APAC Radioisotopes in Medicine Sales 2018-2023 (K Curie)
Figure 32. APAC Radioisotopes in Medicine Revenue 2018-2023 ($ Millions)
Figure 33. Europe Radioisotopes in Medicine Sales 2018-2023 (K Curie)
Figure 34. Europe Radioisotopes in Medicine Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Radioisotopes in Medicine Sales 2018-2023 (K Curie)
Figure 36. Middle East & Africa Radioisotopes in Medicine Revenue 2018-2023 ($ Millions)
Figure 37. Americas Radioisotopes in Medicine Sales Market Share by Country in 2022
Figure 38. Americas Radioisotopes in Medicine Revenue Market Share by Country in 2022
Figure 39. Americas Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
Figure 40. Americas Radioisotopes in Medicine Sales Market Share by Application (2018-2023)
Figure 41. United States Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Radioisotopes in Medicine Sales Market Share by Region in 2022
Figure 46. APAC Radioisotopes in Medicine Revenue Market Share by Regions in 2022
Figure 47. APAC Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
Figure 48. APAC Radioisotopes in Medicine Sales Market Share by Application (2018-2023)
Figure 49. China Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Radioisotopes in Medicine Sales Market Share by Country in 2022
Figure 57. Europe Radioisotopes in Medicine Revenue Market Share by Country in 2022
Figure 58. Europe Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
Figure 59. Europe Radioisotopes in Medicine Sales Market Share by Application (2018-2023)
Figure 60. Germany Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Radioisotopes in Medicine Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Application (2018-2023)
Figure 69. Egypt Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Radioisotopes in Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Radioisotopes in Medicine in 2022
Figure 75. Manufacturing Process Analysis of Radioisotopes in Medicine
Figure 76. Industry Chain Structure of Radioisotopes in Medicine
Figure 77. Channels of Distribution
Figure 78. Global Radioisotopes in Medicine Sales Market Forecast by Region (2024-2029)
Figure 79. Global Radioisotopes in Medicine Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Radioisotopes in Medicine Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Radioisotopes in Medicine Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Radioisotopes in Medicine Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Radioisotopes in Medicine Revenue Market Share Forecast by Application (2024-2029)
